Western blot analysis of extracts from NIH/3T3, PC12 and COS cells, using p44/42 MAP Kinase (L34F12) Mouse mAb.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using p44/42 MAP Kinase (L34F12) Mouse mAb in the presence of control peptide (left) or p44/42 MAP Kinase Blocking Peptide (#4696 Specific) #1245 (right).
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, showing cytoplasmic and nuclear localization, using p44/42 MAP Kinase (L34F12) Mouse mAb.
Confocal immunofluorescent analysis of NIH/3T3 cells, either U0126-treated (#9903, 10 μM, 2 hour, left) or PDGF-treated (#9909, 100 ng/ml, 20 min, right), using p44/42 MAP Kinase (L34F12) Mouse mAb (green). Actin filaments have been labeled with DY-554 phalloidin (red).
Flow cytometric analysis of Jurkat cells, U0126-treated (blue) or PMA-treated (green), using p44/42 MAP Kinase (L34F12) Mouse mAb compared to a nonspecific negative control antibody (red).